| Market Size 2024 (Base Year) | USD 3.42 Billion |
| Market Size 2032 (Forecast Year) | USD 37.86 Billion |
| CAGR | 35.07% |
| Forecast Period | 2025 - 2032 |
| Historical Period | 2020 - 2024 |
The report covers a detailed analysis and forecast for the global ai medicine software market on a global and regional level from 2021 to 2028. The study offers historical data from 2016 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million). The study comprises a comprehensive view of the market with a review of market drivers, restraints, and opportunities. It also provides the level of impact of drivers and restraints on the ai medicine software market between 2021 and 2028.
These assessments help users of the report to analyze the ai medicine software market on the basis of different metrics that includes brand loyalty, switching costs, capital investments, economies of scale, regulatory legislation, current sales networks, production rights and patents, customer preferences, and promotional effects. This categorized data is expected to aid industry stakeholders in decision-making.The study also suggests company penetration plans for new entrants. Furthermore, the ai medicine software industry study report has listed the main manufacturers and distributors operating in all the major regions. We anticipate that this analysis and data will assist industry players to strengthen their networks of market penetration and expand their geographical breadth as a result of their efforts.
Market Research Store (MRS) published a latest report titled “AI Medicine Software Market research report which is segmented by Products (Machine Learning, Natural Language Processing, Others), by Applications (Drug Discovery, Precision Medicine, Others), by Key Players/Companies (Tempus Labs Inc., Flatiron Health Inc., Gene42 Inc., Sunquest Information Systems Inc, 2bPrecise LLC, NantHealth Inc, IBM Watson Group, Human Longevity Inc., N-of-One Inc., Translational Software Inc, SOPHiA GENETICS SA, Syapse Inc., LifeOmic Health LLC, PierianDx Inc, Fabric Genomics, Foundation Medicine Inc., Koninklijke Philips N.V.)”. In 2020, the global ai medicine software market demand was registered at XX (USD Million) and is predicted to reach XX (USD Million) at a CAGR of XX% by 2028.
| Report Attributes | Report Details |
|---|---|
| Report Title | AI Medicine Software Market Research Report |
| By Products | Machine Learning, Natural Language Processing, Others |
| By Applications | Drug Discovery, Precision Medicine, Others |
| By Key Players | Tempus Labs Inc., Flatiron Health Inc., Gene42 Inc., Sunquest Information Systems Inc, 2bPrecise LLC, NantHealth Inc, IBM Watson Group, Human Longevity Inc., N-of-One Inc., Translational Software Inc, SOPHiA GENETICS SA, Syapse Inc., LifeOmic Health LLC, PierianDx Inc, Fabric Genomics, Foundation Medicine Inc., Koninklijke Philips N.V. |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 123 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
The study includes a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porter’s Five Forces model to analyze the different factors affecting the growth of the ai medicine software market. Furthermore, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by products, applications, and region. Additionally, the report also covers the exhaustive regulatory landscape, technology landscape, value chain analysis and PEST analysis.
Request Free Sample
Request Free Sample
The epidemic of COVID-19 has caused significant economic and social upheaval. The pandemic has had an influence on the supply chain and value chain of numerous businesses. The ai medicine software market is not an exception. The impact of the COVID-19 pandemic will be analyzed on the basis of the overall industry including both the demand side and supply side perspectives. The effects of the pandemic would be studied and analyzed for short-term and long-term scenarios. This would assist to formulate business strategies for the period during the pandemic as well as the post-pandemic period for all stakeholders involved in the industry including suppliers, manufacturers, vendors, distributors, and end-users.
The report study delivers a critical assessment on the ai medicine software by segmenting the total addressable market based on products, applications, and region. All the segments & categories of the ai medicine software market are evaluated on the basis of past and future trends. The data for the market and its segments & categories are provided from 2016 to 2028. The report has identified the important segments & categories offering the most to the total addressable market growth in terms of revenue as well as the factors advancing their development.
The report includes a detailed segment analysis of the ai medicine software market based on products, applications, and region. On the basis of Products, the market can be classified into Machine Learning, Natural Language Processing, Others. Based on the Applications, the market can be segmented into the Drug Discovery, Precision Medicine, Others.
The report provides exhaustive information on all the key players in the industry based on company overview, company market share, recent developments, business strategies, and financial performance among others. The report will also provide an extensive product portfolio for each company along with detailed descriptions/features. This report also contains useful recommendations for both established and new players around the world.
Some of the key players in the ai medicine software market include:
Due to the existence of multiple significant competitors, the industry is very competitive. Several inorganic growth techniques, such as acquisitions, mergers, and regional expansion are being pursued by the majority of manufacturers in order to increase their market share and obtain a competitive edge.
The report provides market size for all the segments and their categories for regions that include North America, Europe, Asia Pacific (APAC), Latin America and the Middle East & Africa (MEA). These regions are further bifurcated into major countries including the U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others. The report has analyzed both developed & developing regions considered for research of the ai medicine software market. To assist firms in developing effective development strategies, the regional analysis section provides a complete overview of the industry from a number of countries and regions.
Request Free SampleINQUIRY_TEXT
The findings would be further affirmed and expanded upon through primary research conducted with industry professionals and decision-makers from around the world. A wide range of data validation and market estimation approaches were used to further assemble and validate the results gathered during the research. We also have our data forecasting algorithm that projects market growth over the year 2028. We performed both primary and secondary research to gain a clear overview of the ai medicine software market. This helped us understand existing market dynamics like supply-demand imbalance, pricing trends, product preferences, consumer behavior, and other factors.
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global AI Medicine Software Market Share by Type (2020-2026) 1.5.2 Machine Learning 1.5.3 Natural Language Processing 1.5.4 Others 1.6 Market by Application 1.6.1 Global AI Medicine Software Market Share by Application (2020-2026) 1.6.2 Drug Discovery 1.6.3 Precision Medicine 1.6.4 Others 1.7 AI Medicine Software Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on AI Medicine Software Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of AI Medicine Software Market 3.1 Value Chain Status 3.2 AI Medicine Software Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of AI Medicine Software 3.2.3 Labor Cost of AI Medicine Software 3.2.3.1 Labor Cost of AI Medicine Software Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 Tempus Labs, Inc. 4.1.1 Tempus Labs, Inc. Basic Information 4.1.2 AI Medicine Software Product Profiles, Application and Specification 4.1.3 Tempus Labs, Inc. AI Medicine Software Market Performance (2015-2020) 4.1.4 Tempus Labs, Inc. Business Overview 4.2 Flatiron Health, Inc. 4.2.1 Flatiron Health, Inc. Basic Information 4.2.2 AI Medicine Software Product Profiles, Application and Specification 4.2.3 Flatiron Health, Inc. AI Medicine Software Market Performance (2015-2020) 4.2.4 Flatiron Health, Inc. Business Overview 4.3 Gene42, Inc. 4.3.1 Gene42, Inc. Basic Information 4.3.2 AI Medicine Software Product Profiles, Application and Specification 4.3.3 Gene42, Inc. AI Medicine Software Market Performance (2015-2020) 4.3.4 Gene42, Inc. Business Overview 4.4 Sunquest Information Systems Inc 4.4.1 Sunquest Information Systems Inc Basic Information 4.4.2 AI Medicine Software Product Profiles, Application and Specification 4.4.3 Sunquest Information Systems Inc AI Medicine Software Market Performance (2015-2020) 4.4.4 Sunquest Information Systems Inc Business Overview 4.5 2bPrecise LLC 4.5.1 2bPrecise LLC Basic Information 4.5.2 AI Medicine Software Product Profiles, Application and Specification 4.5.3 2bPrecise LLC AI Medicine Software Market Performance (2015-2020) 4.5.4 2bPrecise LLC Business Overview 4.6 NantHealth, Inc 4.6.1 NantHealth, Inc Basic Information 4.6.2 AI Medicine Software Product Profiles, Application and Specification 4.6.3 NantHealth, Inc AI Medicine Software Market Performance (2015-2020) 4.6.4 NantHealth, Inc Business Overview 4.7 IBM Watson Group 4.7.1 IBM Watson Group Basic Information 4.7.2 AI Medicine Software Product Profiles, Application and Specification 4.7.3 IBM Watson Group AI Medicine Software Market Performance (2015-2020) 4.7.4 IBM Watson Group Business Overview 4.8 Human Longevity, Inc. 4.8.1 Human Longevity, Inc. Basic Information 4.8.2 AI Medicine Software Product Profiles, Application and Specification 4.8.3 Human Longevity, Inc. AI Medicine Software Market Performance (2015-2020) 4.8.4 Human Longevity, Inc. Business Overview 4.9 N-of-One, Inc. 4.9.1 N-of-One, Inc. Basic Information 4.9.2 AI Medicine Software Product Profiles, Application and Specification 4.9.3 N-of-One, Inc. AI Medicine Software Market Performance (2015-2020) 4.9.4 N-of-One, Inc. Business Overview 4.10 Translational Software, Inc 4.10.1 Translational Software, Inc Basic Information 4.10.2 AI Medicine Software Product Profiles, Application and Specification 4.10.3 Translational Software, Inc AI Medicine Software Market Performance (2015-2020) 4.10.4 Translational Software, Inc Business Overview 4.11 SOPHiA GENETICS SA 4.11.1 SOPHiA GENETICS SA Basic Information 4.11.2 AI Medicine Software Product Profiles, Application and Specification 4.11.3 SOPHiA GENETICS SA AI Medicine Software Market Performance (2015-2020) 4.11.4 SOPHiA GENETICS SA Business Overview 4.12 Syapse, Inc. 4.12.1 Syapse, Inc. Basic Information 4.12.2 AI Medicine Software Product Profiles, Application and Specification 4.12.3 Syapse, Inc. AI Medicine Software Market Performance (2015-2020) 4.12.4 Syapse, Inc. Business Overview 4.13 LifeOmic Health, LLC 4.13.1 LifeOmic Health, LLC Basic Information 4.13.2 AI Medicine Software Product Profiles, Application and Specification 4.13.3 LifeOmic Health, LLC AI Medicine Software Market Performance (2015-2020) 4.13.4 LifeOmic Health, LLC Business Overview 4.14 PierianDx, Inc 4.14.1 PierianDx, Inc Basic Information 4.14.2 AI Medicine Software Product Profiles, Application and Specification 4.14.3 PierianDx, Inc AI Medicine Software Market Performance (2015-2020) 4.14.4 PierianDx, Inc Business Overview 4.15 Fabric Genomics 4.15.1 Fabric Genomics Basic Information 4.15.2 AI Medicine Software Product Profiles, Application and Specification 4.15.3 Fabric Genomics AI Medicine Software Market Performance (2015-2020) 4.15.4 Fabric Genomics Business Overview 4.16 Foundation Medicine, Inc. 4.16.1 Foundation Medicine, Inc. Basic Information 4.16.2 AI Medicine Software Product Profiles, Application and Specification 4.16.3 Foundation Medicine, Inc. AI Medicine Software Market Performance (2015-2020) 4.16.4 Foundation Medicine, Inc. Business Overview 4.17 Koninklijke Philips N.V. 4.17.1 Koninklijke Philips N.V. Basic Information 4.17.2 AI Medicine Software Product Profiles, Application and Specification 4.17.3 Koninklijke Philips N.V. AI Medicine Software Market Performance (2015-2020) 4.17.4 Koninklijke Philips N.V. Business Overview 5 Global AI Medicine Software Market Analysis by Regions 5.1 Global AI Medicine Software Sales, Revenue and Market Share by Regions 5.1.1 Global AI Medicine Software Sales by Regions (2015-2020) 5.1.2 Global AI Medicine Software Revenue by Regions (2015-2020) 5.2 North America AI Medicine Software Sales and Growth Rate (2015-2020) 5.3 Europe AI Medicine Software Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific AI Medicine Software Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa AI Medicine Software Sales and Growth Rate (2015-2020) 5.6 South America AI Medicine Software Sales and Growth Rate (2015-2020) 6 North America AI Medicine Software Market Analysis by Countries 6.1 North America AI Medicine Software Sales, Revenue and Market Share by Countries 6.1.1 North America AI Medicine Software Sales by Countries (2015-2020) 6.1.2 North America AI Medicine Software Revenue by Countries (2015-2020) 6.1.3 North America AI Medicine Software Market Under COVID-19 6.2 United States AI Medicine Software Sales and Growth Rate (2015-2020) 6.2.1 United States AI Medicine Software Market Under COVID-19 6.3 Canada AI Medicine Software Sales and Growth Rate (2015-2020) 6.4 Mexico AI Medicine Software Sales and Growth Rate (2015-2020) 7 Europe AI Medicine Software Market Analysis by Countries 7.1 Europe AI Medicine Software Sales, Revenue and Market Share by Countries 7.1.1 Europe AI Medicine Software Sales by Countries (2015-2020) 7.1.2 Europe AI Medicine Software Revenue by Countries (2015-2020) 7.1.3 Europe AI Medicine Software Market Under COVID-19 7.2 Germany AI Medicine Software Sales and Growth Rate (2015-2020) 7.2.1 Germany AI Medicine Software Market Under COVID-19 7.3 UK AI Medicine Software Sales and Growth Rate (2015-2020) 7.3.1 UK AI Medicine Software Market Under COVID-19 7.4 France AI Medicine Software Sales and Growth Rate (2015-2020) 7.4.1 France AI Medicine Software Market Under COVID-19 7.5 Italy AI Medicine Software Sales and Growth Rate (2015-2020) 7.5.1 Italy AI Medicine Software Market Under COVID-19 7.6 Spain AI Medicine Software Sales and Growth Rate (2015-2020) 7.6.1 Spain AI Medicine Software Market Under COVID-19 7.7 Russia AI Medicine Software Sales and Growth Rate (2015-2020) 7.7.1 Russia AI Medicine Software Market Under COVID-19 8 Asia-Pacific AI Medicine Software Market Analysis by Countries 8.1 Asia-Pacific AI Medicine Software Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific AI Medicine Software Sales by Countries (2015-2020) 8.1.2 Asia-Pacific AI Medicine Software Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific AI Medicine Software Market Under COVID-19 8.2 China AI Medicine Software Sales and Growth Rate (2015-2020) 8.2.1 China AI Medicine Software Market Under COVID-19 8.3 Japan AI Medicine Software Sales and Growth Rate (2015-2020) 8.3.1 Japan AI Medicine Software Market Under COVID-19 8.4 South Korea AI Medicine Software Sales and Growth Rate (2015-2020) 8.4.1 South Korea AI Medicine Software Market Under COVID-19 8.5 Australia AI Medicine Software Sales and Growth Rate (2015-2020) 8.6 India AI Medicine Software Sales and Growth Rate (2015-2020) 8.6.1 India AI Medicine Software Market Under COVID-19 8.7 Southeast Asia AI Medicine Software Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia AI Medicine Software Market Under COVID-19 9 Middle East and Africa AI Medicine Software Market Analysis by Countries 9.1 Middle East and Africa AI Medicine Software Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa AI Medicine Software Sales by Countries (2015-2020) 9.1.2 Middle East and Africa AI Medicine Software Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa AI Medicine Software Market Under COVID-19 9.2 Saudi Arabia AI Medicine Software Sales and Growth Rate (2015-2020) 9.3 UAE AI Medicine Software Sales and Growth Rate (2015-2020) 9.4 Egypt AI Medicine Software Sales and Growth Rate (2015-2020) 9.5 Nigeria AI Medicine Software Sales and Growth Rate (2015-2020) 9.6 South Africa AI Medicine Software Sales and Growth Rate (2015-2020) 10 South America AI Medicine Software Market Analysis by Countries 10.1 South America AI Medicine Software Sales, Revenue and Market Share by Countries 10.1.1 South America AI Medicine Software Sales by Countries (2015-2020) 10.1.2 South America AI Medicine Software Revenue by Countries (2015-2020) 10.1.3 South America AI Medicine Software Market Under COVID-19 10.2 Brazil AI Medicine Software Sales and Growth Rate (2015-2020) 10.2.1 Brazil AI Medicine Software Market Under COVID-19 10.3 Argentina AI Medicine Software Sales and Growth Rate (2015-2020) 10.4 Columbia AI Medicine Software Sales and Growth Rate (2015-2020) 10.5 Chile AI Medicine Software Sales and Growth Rate (2015-2020) 11 Global AI Medicine Software Market Segment by Types 11.1 Global AI Medicine Software Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global AI Medicine Software Sales and Market Share by Types (2015-2020) 11.1.2 Global AI Medicine Software Revenue and Market Share by Types (2015-2020) 11.2 Machine Learning Sales and Price (2015-2020) 11.3 Natural Language Processing Sales and Price (2015-2020) 11.4 Others Sales and Price (2015-2020) 12 Global AI Medicine Software Market Segment by Applications 12.1 Global AI Medicine Software Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global AI Medicine Software Sales and Market Share by Applications (2015-2020) 12.1.2 Global AI Medicine Software Revenue and Market Share by Applications (2015-2020) 12.2 Drug Discovery Sales, Revenue and Growth Rate (2015-2020) 12.3 Precision Medicine Sales, Revenue and Growth Rate (2015-2020) 12.4 Others Sales, Revenue and Growth Rate (2015-2020) 13 AI Medicine Software Market Forecast by Regions (2020-2026) 13.1 Global AI Medicine Software Sales, Revenue and Growth Rate (2020-2026) 13.2 AI Medicine Software Market Forecast by Regions (2020-2026) 13.2.1 North America AI Medicine Software Market Forecast (2020-2026) 13.2.2 Europe AI Medicine Software Market Forecast (2020-2026) 13.2.3 Asia-Pacific AI Medicine Software Market Forecast (2020-2026) 13.2.4 Middle East and Africa AI Medicine Software Market Forecast (2020-2026) 13.2.5 South America AI Medicine Software Market Forecast (2020-2026) 13.3 AI Medicine Software Market Forecast by Types (2020-2026) 13.4 AI Medicine Software Market Forecast by Applications (2020-2026) 13.5 AI Medicine Software Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source
AI Medicine Software
AI Medicine Software
×